IR contact detailsRoman Akbar-HaaseDirector Investor Relations and Business Developmente: ir@moonlaketx.com Upcoming events Apr 13 - Apr 16 2026 25th Annual Needham Virtual Healthcare Conference, Virtual Apr 14 - Apr 15 2026 4th Annual Inflammatory Skin Disease Virtual Conference, Virtual Apr 15 - Apr 16 2026 Van Lanschot Kempen Life Sciences Conference, Amsterdam, Netherlands View All Events View All Events + Corporate presentations MoonLake Investor Day (Feb 2026) Clinical Data Update (Nov 2025) View All Presentations View All Presentations + Latest press releases Mar 28 2026 MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting Feb 22 2026 MoonLake Announces Positive Topline Results from its Phase 2 Clinical Trial of Sonelokimab in Axial Spondyloarthritis and Reports 2025 Financial Results Feb 02 2026 MoonLake Announces FDA Fast Track Designation for Sonelokimab Palmoplantar Pustulosis (PPP) and Provides Details on Upcoming Investor Day View All News View All Press Releases +
Mar 28 2026 MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting
Feb 22 2026 MoonLake Announces Positive Topline Results from its Phase 2 Clinical Trial of Sonelokimab in Axial Spondyloarthritis and Reports 2025 Financial Results
Feb 02 2026 MoonLake Announces FDA Fast Track Designation for Sonelokimab Palmoplantar Pustulosis (PPP) and Provides Details on Upcoming Investor Day